May 2016

Pharma Insights
Companion Diagnostics and Complementary Diagnostics in Clinical Practice: Better Medicine or Competitive Disadvantage?
David Parker, PhD; Larry Blandford, PharmD—Column Editor

J Clin Pathways. 2016;2(4):25.

Departments

Research in Review
FACT-B Most Effective Health-Related Quality of Life Instrument for Breast Cancer
JCP Editors

J Clin Pathways. 2016;2(4):10-13.

Research in Review
Increasing Use of Percutaneous Liver Biopsy Accompanied by Growing Costs
JCP Editors

J Clin Pathways. 2016;2(4):10-13.

Research in Review
NCCN-Recommended Therapy for Ovarian Cancer Currently Underused in Medicare Patients
JCP Editors

J Clin Pathways. 2016;2(4):10-13.

Research in Review
Hormone Therapy More Cost-Effective Than Chemotherapy for Patients With HR+/HER2- Metastatic Breast Cancer
JCP Editors

J Clin Pathways. 2016;2(4):10-13.

Interview
An Alliance to Reform the Current Health Care System

J Clin Pathways. 2016;2(4):18-20.

Editor's Page
For Buy-In of the Clinical Pathways Concept, Transparency Is Key
Winston Wong, PharmD, Editor-in-Chief

J Clin Pathways. 2016;2(4):9.

Features

Research Report
Cost-Effectiveness of Afatinib Versus Erlotinib in the First-line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer With EGFR Exon 19 Deletion Mutations
Jonathan Graham, BS; Stephanie Earnshaw, PhD; Jonathan Lim, BS, MS, MSc; Rakesh Luthra, MS; Rohit Borker, PhD

J Clin Pathways. 2016;2(4):31-39. Received March 25, 2016; accepted April 14, 2016.

From the Field
Mock Clinical Pathways: A Method for Exploring the Oncology Clinical Pathway Development Process
Bruce Feinberg, DO; Monica Lingam, MS; Bing-E Xu, PhD

J Clin Pathways. 2016;2(4):41-46. Received April 1, 2016; accepted April 12, 2016.

Counterpoint
Keeping Cures on the Shelf
George Dahlman

J Clin Pathways. 2016;2(4):29-30.

Columns

Clinical Pathways GPS
Hitting Each Component of the Triple Aim Along the Clinical Pathway
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor; Scott Guerin, PhD; Seth Gordon, MBA

J Clin Pathways. 2016;2(4):21-23.

Back to Top